# Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer

> **NIH NIH R01** · UNIVERSITY OF TX MD ANDERSON CAN CTR · 2020 · $92,860

## Abstract

Abstract
Abstract not requested.
This is an NCI Diversity Supplement to Dr. Cullen Taniguchi's Grant# 1R01CA227517-01A1, titled, Translating
Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer.

## Key facts

- **NIH application ID:** 10134891
- **Project number:** 3R01CA227517-02S1
- **Recipient organization:** UNIVERSITY OF TX MD ANDERSON CAN CTR
- **Principal Investigator:** Cullen Mitsuo Taniguchi
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $92,860
- **Award type:** 3
- **Project period:** 2019-04-01 → 2024-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10134891

## Citation

> US National Institutes of Health, RePORTER application 10134891, Translating Intestinal Radioprotection by EGLN Inhibition to Improve Clinical Outcomes in Unresectable Pancreatic Cancer (3R01CA227517-02S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10134891. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*